Abbott Laboratories
ABT
$97.04
Share price
0.19%
Change (1 day)
-17.00%
Change (1 year)
Categories
Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.
Earnings for Abbott Laboratories (ABT)
Earnings in 2022 (TTM): $8.30 B
According to Abbott Laboratories's latest financial reports the company's current earnings (TTM) are $8.30 B. In 2021 the company made an earning of $8.21 B an increase over its 2020 earnings that were of $4.96 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Abbott Laboratories from 2001 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $8.30 B | 1.16% |
| 2021 | $8.21 B | 65.28% |
| 2020 | $4.96 B | 21.85% |
| 2019 | $4.07 B | 41.91% |
| 2018 | $2.87 B | 28.78% |
| 2017 | $2.23 B | 57.89% |
| 2016 | $1.41 B | -55.61% |
| 2015 | $3.18 B | 18.77% |
| 2014 | $2.68 B | 6.31% |
| 2013 | $2.52 B | -59.75% |
| 2012 | $6.26 B | 20.47% |
| 2011 | $5.19 B | -9% |
| 2010 | $5.71 B | -20.59% |
| 2009 | $7.19 B | 22.84% |
| 2008 | $5.85 B | 33.1% |
| 2007 | $4.39 B | 93.29% |
| 2006 | $2.27 B | -50.73% |
| 2005 | $4.61 B | 9.82% |
| 2004 | $4.20 B | 12.65% |
| 2003 | $3.73 B | 1.66% |
| 2002 | $3.67 B | 95.07% |
| 2001 | $1.88 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.00 B | 164.88% | 🇺🇸 USA |
 Novartis NVS | $8.37 B | 0.78% | 🇨🇭 Switzerland |
 Pfizer PFE | $35.96 B | 333.04% | 🇺🇸 USA |
 Medtronic MDT | $6.00 B | -27.67% | 🇮🇪 Ireland |
 Thermo Fisher Scientific TMO | $7.83 B | -5.67% | 🇺🇸 USA |
 Boston Scientific BSX | $1.14 B | -86.25% | 🇺🇸 USA |
 Hologic HOLX | $1.30 B | -84.31% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $7.71 B | -7.14% | 🇺🇸 USA |
 AstraZeneca AZN | $3.83 B | -53.89% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $7.60 B | -8.48% | 🇬🇧 UK |